MENU
ENTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

A.I. Advisor
published Earnings

ENTX is expected to report earnings to rise 16.67% to -7 cents per share on May 09

Entera Bio ENTX Stock Earnings Reports
Q1'25
Est.
$-0.07
Q4'24
Est.
$-0.06
Q3'24
Missed
by $0.03
Q2'24
Est.
$-0.06
Q1'24
Beat
by $0.07
The last earnings report on March 28 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 14.22K shares outstanding, the current market capitalization sits at 76.31M.
View a ticker or compare two or three
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com